BRISTOL-MYERS SQUIBB COMPANY

Business Segments Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Pharmaceuticals

Market Closed - Nyse Other stock markets 21:00:02 13/02/2026 GMT			5-day change	1st Jan Change
60.74 ^USD	+1.47%		-2.02%	+12.61%

02-11	Tranche Update on Bristol-Myers Squibb Company's Equity Buyback Plan announced on October 27, 2016.	CI
02-09	AstraZeneca's Evinova Enters Clinical Development AI Partnership Deal	MT

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Pharmaceutical Products
Pharmaceuticals						46.38B	46.16B	45.01B	48.3B	48.19B
Total Assets						109B	96.82B	95.16B	92.6B	90.04B
Interest Expense						-1.29B	-1.15B	-1.16B	-1.96B	-1.89B
Income Tax Expense						1.08B	1.37B	400M	554M	2.27B
CAPEX						-973M	-1.12B	-1.21B	-1.25B	-1.31B
EBT						8.1B	7.71B	8.44B	-8.38B	9.33B
D&A						10.76B	10.28B	9.77B	9.58B	4.08B
Net Income						6.99B	6.33B	8.02B	-8.95B	7.05B

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
United States						29.21B	31.83B	31.56B	34.1B	33.28B
Total Assets						4.71B	4.83B	5.04B	4.81B	4.93B
International						-	13.5B	12.75B	13.2B	13.83B
Total Assets						-	1.42B	1.61B	2.32B	2.61B
Unallocated						852M	834M	699M	996M	1.09B
Japan						-	-	-	-	-
Europe						10.69B	-	-	-	-
Total Assets						1.18B	-	-	-	-
Rest of The World						5.63B	-	-	-	-
Total Assets						163M	-	-	-	-

The best tools reserved for subscribers to boost the performance of your investments!